Diabetic Retinopathy and Cardiovascular Disease: A Literature Review

Area of Science:

• Endocrinology and Metabolism
• Ophthalmology
• Cardiology

Background:

• Diabetic complications include macrovascular (e.g., cardiovascular disease - CVD) and microvascular (e.g., diabetic retinopathy - DR) issues.
• CVD is a leading cause of mortality in diabetic patients, while DR contributes significantly to disability.
• Emerging evidence suggests a common pathophysiological basis linking DR and CVD, implying DR may predict CVD risk.

Purpose of the Study:

• To explore the feasibility of using diabetic retinopathy (DR) as a predictor for cardiovascular disease (CVD).
• To review the common pathophysiological mechanisms underlying DR and CVD.
• To discuss advancements in DR diagnostic techniques and identify biomarkers for early DR screening.

Main Methods:

• Review of existing literature on the pathophysiological links between DR and CVD.
• Analysis of technological advancements in quantitative fundus parameter analysis for DR.
• Investigation of cytokines and other biomarkers for early DR detection.

Main Results:

• Quantitative fundus parameters in DR are identified as independent risk factors for CVD.
• Cytokines associated with DR show promise for early DR screening.
• DR and CVD share common underlying pathological pathways, supporting the predictive role of DR.

Conclusions:

• Diabetic retinopathy (DR) holds significant potential as a predictive marker for cardiovascular disease (CVD) due to shared pathophysiology.
• Quantitative fundus analysis and novel biomarkers offer promising strategies for early detection and risk stratification of both DR and CVD.
• Further research into these links could improve preventative strategies and patient outcomes in diabetes management.